Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Oku

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 26, 2018
[The scoring system for the risk-stratification in patients with the antiphospholipid syndrome]Kenji Oku
Rheumatology International|March 20, 2019
Rheumatology practice in Japan: challenges and opportunitiesKenji Oku, Tatsuya Atsumi
Modern Rheumatology|June 28, 2018
Systemic lupus erythematosus: nothing stale her infinite varietyKenji Oku, Tatsuya Atsumi
Immunological Medicine|February 6, 2023
JAK inhibitors in rheumatologyKunihiro Yamaoka, Kenji Oku
European Journal of Clinical Investigation|July 13, 2012
Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndromeKenji Oku, Olga Amengual, Tatsuya Atsumi
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 29, 2014
[The pathogenesis, diagnosis and treatment of antiphospholipid syndrome]Kazumasa Ohmura, Kenji Oku, Tatsuya Atsumi
Current Rheumatology Reports|July 26, 2017
How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated ScoresKenji Oku, Olga Amengual, Shinsuke Yasuda, et al.
Immunological Medicine|June 2, 2025
Alternation of anti-NMDA receptor subunit GluN2 antibody in a patient with SLE who promptly developed anxiety after belimumabYoshiyuki Arinuma, Yasuhiro Hasegawa, Kenji Oku, et al.
Drug Discoveries & Therapeutics|September 5, 2017
Successful treatment with clarithromycin and/or tacrolimus for two patients with polymyalgia rheumaticaMasashi Ohe, Haruki Shida, Tetsuya Horita, et al.
Seminars in Thrombosis and Hemostasis|September 25, 2008
Antiprothrombin antibody testing: detection and clinical utilityKenji Oku, Tatsuya Atsumi, Olga Amengual, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 26, 2018
[The scoring system for the risk-stratification in patients with the antiphospholipid syndrome]Kenji Oku
Rheumatology International|March 20, 2019
Rheumatology practice in Japan: challenges and opportunitiesKenji Oku, Tatsuya Atsumi
Modern Rheumatology|June 28, 2018
Systemic lupus erythematosus: nothing stale her infinite varietyKenji Oku, Tatsuya Atsumi
Immunological Medicine|February 6, 2023
JAK inhibitors in rheumatologyKunihiro Yamaoka, Kenji Oku
European Journal of Clinical Investigation|July 13, 2012
Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndromeKenji Oku, Olga Amengual, Tatsuya Atsumi
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 29, 2014
[The pathogenesis, diagnosis and treatment of antiphospholipid syndrome]Kazumasa Ohmura, Kenji Oku, Tatsuya Atsumi
Current Rheumatology Reports|July 26, 2017
How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated ScoresKenji Oku, Olga Amengual, Shinsuke Yasuda, et al.
Immunological Medicine|June 2, 2025
Alternation of anti-NMDA receptor subunit GluN2 antibody in a patient with SLE who promptly developed anxiety after belimumabYoshiyuki Arinuma, Yasuhiro Hasegawa, Kenji Oku, et al.
Drug Discoveries & Therapeutics|September 5, 2017
Successful treatment with clarithromycin and/or tacrolimus for two patients with polymyalgia rheumaticaMasashi Ohe, Haruki Shida, Tetsuya Horita, et al.
Seminars in Thrombosis and Hemostasis|September 25, 2008
Antiprothrombin antibody testing: detection and clinical utilityKenji Oku, Tatsuya Atsumi, Olga Amengual, et al.
Pageof 9